PT - JOURNAL ARTICLE AU - Polverino, Arianna AU - Lopez, Emahnuel Troisi AU - Minino, Roberta AU - Liparoti, Marianna AU - Romano, Antonella AU - Trojsi, Francesca AU - Lucidi, Fabio AU - Gollo, Leonardo L. AU - Jirsa, Viktor AU - Sorrentino, Giuseppe AU - Sorrentino, Pierpaolo TI - Flexibility of brain dynamics predicts clinical impairment in Amyotrophic Lateral Sclerosis AID - 10.1101/2022.02.07.22270581 DP - 2022 Jan 01 TA - medRxiv PG - 2022.02.07.22270581 4099 - http://medrxiv.org/content/early/2022/02/07/2022.02.07.22270581.short 4100 - http://medrxiv.org/content/early/2022/02/07/2022.02.07.22270581.full AB - Amyotrophic lateral sclerosis (ALS) is a multisystem disorder. This view is widely supported by clinical, molecular and neuroimaging evidence. As a consequence, predicting clinical features requires a comprehensive description of large-scale brain activity. Flexible dynamics is key to support complex adaptive responses. In health, brain activity reconfigures over time, involving different brain areas. Brain pathologies can induce more stereotyped dynamics, which, in turn, are linked to clinical impairment. Hence, based on recent evidence that brain functional networks become more connected as ALS progresses, we hypothesized that loss of flexible dynamics in ALS would predict their clinical condition.To test this hypothesis, we quantified flexibility utilizing the “functional repertoire” (i.e. the number of unique patterns) expressed during the magnetoencephalography (MEG) recording, based on source-reconstructed signals. Specifically, 42 ALS patients and 42 healthy controls underwent MEG and MRI recordings. The activity of the brain areas was reconstructed in the classical frequency bands, and the functional repertoire was estimated to quantify spatio-temporal fluctuations of brain activity. In order to verify if the functional repertoire predicted disease severity, we built a multilinear model and validated it using a k-fold cross validation scheme.The comparison between the two groups revealed that ALS patients showed more stereotyped brain dynamics (P < 0.05), with reduced size of the functional repertoire. The relationship between the size of the functional repertoire and the clinical scores in the ALS group was investigated using Spearman’s coefficient, showing significant correlations in both the delta and the theta frequency bands. In order to prove the robustness of our results, the k-fold cross validation model was used. We found that the functional repertoire significantly predicted both clinical staging (P < 0.001 and P < 0.01, in delta and theta bands, respectively) and impairment (P < 0.001, in both delta and theta bands).In conclusion, our work shows that: 1) ALS pathology reduces the flexibility of brain dynamics; 2) sub-cortical regions play a key role in determining brain dynamics; 3) reduced brain flexibility predicts the stage of the disease as well as the severity of the symptoms. Based on these findings, our approach provides a non-invasive tool to quantify alterations in brain dynamics in ALS (and, possibly, other neurodegenerative diseases), thus opening new diagnostic opportunities as well as a framework to test disease-modifying interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by University of Naples Parthenope within the Project Bando Ricerca Competitiva 2017 (D.R. 289/2017) (GS), by University of Naples Parthenope within the Project Ricerca Locale, 2018 (GS), by the European Union s Horizon 2020 Research and Innovation Program under grant agreement No. 945539 (SGA3) Human Brain Project (VJ, PS), and by grant agreement No. 826421 Virtual Brain Cloud (VJ, PS). LLG is funded by NHMRC-ARC fellowship ID: APP1110975.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Campania Luigi Vanvitelli gave ethical approval for this work with protocol number 591/2018.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsAALAutomated Anatomical LabelingALSAmyotrophic Lateral SclerosisALSFRS-RAmyotrophic Lateral Sclerosis Functional Rating Scale-RevisedbvFTDbehavioral variant of Frontotemporal DementiaFDRFalse Discovery RateICAIndependent Component AnalysisLCMVLinearly Constrained Minimum VarianceLOOCVleave-one-out cross validationMEGMagnetoencephalographyMiToSMilano-Torino StagingPCAPrincipal Component AnalysisROIsRegions of InterestTDP-43TAR-DNA binding protein-43